Atlas Trials

A Dose-proportionality Study of Five Tablet Strengths of ER OROS Paliperidone

Clinical trial NCT00796835 · COMPLETED

Trial details

NCT number
NCT00796835
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2004-07-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.